Aurobindo Pharma is recalling 7,476 bottles of Metformin Hydrochloride Tablets, USP 1000 mg (generic Glucophage) because a foreign tablet, identified as Metformin BP 1000mg, was found inside a bottle. While both tablets contain the same active ingredient and dosage, the foreign tablet was not intended for the US market and does not meet the specific US product appearance or regulatory standards. Consumers who take this prescription medication for diabetes management should check their bottle for the specific lot number affected by this mix-up.
The presence of a foreign tablet in a prescription bottle indicates a packaging error. While the foreign tablet contains the correct dosage of the medication, it may not dissolve or be absorbed by the body in the same way as the prescribed US version, potentially leading to inconsistent blood sugar control.
Healthcare provider consultation and pharmacy refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.